Admelog recalls
Admelog products have been recalled 2 times, most recently on 24 May 2023. The recalling company is usually Sanofi-Aventis U.S. The most common reason is sterility.
Total recalls2since 2018
Last 12 months0reported
Class I00% of total
Ongoing2latest 24 May 2023
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why admelog is recalled
Companies
Product types
By year
Ongoing admelog recalls
2 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Admelog, insulin lispro injection/mL (U-100) multi-dose vial recalledAdmelog | Sanofi-Aventis U.S | Sterility | Nationwide |
| Drug | CLASS II | Admelog Solostar (insulin lispro injection)/ mL (U-100) injection recalledAdmelog | Sanofi-Aventis U.S | Packaging Defects | Nationwide |
All admelog recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Admelog, insulin lispro injection/mL (U-100) multi-dose vial recalledAdmelog | Sanofi-Aventis U.S | Sterility | Nationwide |
| Drug | CLASS II | Admelog Solostar (insulin lispro injection)/ mL (U-100) injection recalledAdmelog | Sanofi-Aventis U.S | Packaging Defects | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.